This is a disclosure report regarding direct/indirect conflicts of interest of a financial, functional or any other nature related to commercial and non-commercial organizations.
Commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature (for the period of January-March 2023)
- Member of Board of Directors (Current):
- 4D Pharma (chairperson)
- Active Biotech AB
- Ryvu Therapeutics S.A.
- Consultancy/other honoraria (2021-2023):
- Bristol-Myers Squibb
- Active Biotech AB
- Nanexa AB
- Cellex GmbH
- Ryvu Therapeutics S.A.
- Oncopeptides AB
Non-commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature
- None
Last updated on 25 April 2023